Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Petr, Kujal"'
Autor:
Martina Hüttl, Irena Markova, Denisa Miklánková, Iveta Zapletalova, Petr Kujal, Jan Šilhavý, Michal Pravenec, Hana Malinska
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background and aims: Low-grade chronic inflammation plays an important role in the pathogenesis of metabolic syndrome, type 2 diabetes and their complications. In this study, we investigated the effects of salsalate, a non-steroidal anti-inflammatory
Externí odkaz:
https://doaj.org/article/43d18ec3736b4092867a31a16cc3da06
Autor:
Zuzana Honetschlagerová, Petra Škaroupková, Soňa Kikerlová, Zuzana Husková, Hana Maxová, Vojtěch Melenovský, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Olga Gawrys, Petr Kujal, Luděk Červenka, Věra Čertíková Chábová
Publikováno v:
Clinical and Experimental Hypertension, Vol 43, Iss 6, Pp 522-535 (2021)
Background: The coincidence of congestive heart failure (CHF) and chronic kidney disease (CKD) results in poor survival rate. The aim of the study was to examine if renal denervation (RDN) would improve the survival rate in CHF induced by creation of
Externí odkaz:
https://doaj.org/article/285e238d66e241cf8f0f478fd8e52e22
Autor:
Zuzana Honetschlagerová, Olga Gawrys, Šárka Jíchová, Petra Škaroupková, Soňa Kikerlová, Zdeňka Vaňourková, Zuzana Husková, Vojtěch Melenovský, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, František Kolář, Jiří Novotný, Lucie Hejnová, Petr Kujal, Luděk Červenka
Publikováno v:
Kidney & Blood Pressure Research, Vol 46, Iss 1, Pp 95-113 (2021)
Objective: We examined if renal denervation (RDN) attenuates the progression of aortocaval fistula (ACF)-induced heart failure or improves renal hemodynamics in Ren-2 transgenic rats (TGR), a model of angiotensin II (ANG II)-dependent hypertension. M
Externí odkaz:
https://doaj.org/article/4342976b6d9244e0932ca104bb0b46fe
Autor:
Věra Čertíková Chábová, Petr Kujal, Zdeňka Vaňourková, Petra Škaroupková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Vladimír Tesař, Bruce Hammock, John Imig, Hana Maxová, Luděk Červenka, Ivana Vaněčková
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 6, Pp 1493-1505 (2019)
Introduction: Previous studies in Ren-2 transgenic hypertensive rats (TGR) after 5/6 renal ablation (5/6 NX) have shown that besides pharmacological blockade of the renin-angiotensin system (RAS) also increasing kidney tissue epoxyeicosatrienoic acid
Externí odkaz:
https://doaj.org/article/e825f8319c354c929117bd918f0dbf1d
Autor:
Silvie Hojná, Zoe Kotsaridou, Zdeňka Vaňourková, Hana Rauchová, Michal Behuliak, Petr Kujal, Michaela Kadlecová, Josef Zicha, Ivana Vaněčková
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2509 (2022)
Gliflozins (sodium-glucose transporter-2 inhibitors) exhibited renoprotective effects not only in diabetic but also in non-diabetic patients with chronic kidney disease (CKD). Controversial results were reported in experimental non-diabetic models of
Externí odkaz:
https://doaj.org/article/c1aa47ac95cc44c1b6738ee49f9010da
Autor:
Věra Čertíková Chábová, Petr Kujal, Petra Škaroupková, Zdeňka Varňourková, Šárka Vacková, Zuzana Husková, Soňa Kikerlová, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Iwona Baranowska, Sung Hee Hwang, Bruce D. Hammock, John D. Imig, Vladimír Tesař, Ludek Červenka
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 2, Pp 329-349 (2018)
Background/Aims: We found recently that increasing renal epoxyeicosatrienoic acids (EETs) levels by blocking soluble epoxide hydrolase (sEH), an enzyme responsible for EETs degradation, shows renoprotective actions and retards the progression of chro
Externí odkaz:
https://doaj.org/article/11b36c3fd958496eb6b6610466ba58ff
Autor:
Lenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Zuzana Husková, Lenka Červenková, Soňa Kikerlová, Ivana Vaněčková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Petr Kujal, Herbert J. Kramer, Luděk Červenka
Publikováno v:
Clinical and Experimental Hypertension, Vol 39, Iss 2, Pp 183-195 (2017)
Background: Early addition of endothelin (ET) type A (ETA) receptor blockade to complex renin–angiotensin system (RAS) blockade has previously been shown to provide better renoprotection against progression of chronic kidney disease (CKD) in Ren-2
Externí odkaz:
https://doaj.org/article/069801b85c634eb1ad2d34b86397326b
Autor:
Vojtěch Melenovský, Elzbieta Kompanowska-Jezierska, Věra Čertíková Chábová, Zuzana Husková, H. Maxová, Janusz Sadowski, Olga Gawrys, Petra Škaroupková, Zuzana Honetschlägerová, Petr Kujal, Luděk Červenka, Soňa Kikerlová
Publikováno v:
Clinical and Experimental Hypertension. 43:522-535
Background: The coincidence of congestive heart failure (CHF) and chronic kidney disease (CKD) results in poor survival rate. The aim of the study was to examine if renal denervation (RDN) would improve the survival rate in CHF induced by creation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99b60f1cb39f53a41d1634c68b0b2a6
https://doi.org/10.1080/10641963.2021.1907398
https://doi.org/10.1080/10641963.2021.1907398
Autor:
František Kolář, Jiří Novotný, Lucie Hejnova, Petr Kujal, Zdeňka Vaňourková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Soňa Kikerlová, Šárka Jíchová, Zuzana Husková, Olga Gawrys, Luděk Červenka, Zuzana Honetschlägerová, Vojtěch Melenovský, Petra Škaroupková
Publikováno v:
Kidney & Blood Pressure Research, Vol 46, Iss 1, Pp 95-113 (2021)
Objective: We examined if renal denervation (RDN) attenuates the progression of aortocaval fistula (ACF)-induced heart failure or improves renal hemodynamics in Ren-2 transgenic rats (TGR), a model of angiotensin II (ANG II)-dependent hypertension. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8281abb04e79ad2defb28692f48f0c
https://www.karger.com/Article/FullText/513071
https://www.karger.com/Article/FullText/513071
Autor:
Jiri Skala-Rosenbaum, Matej Daniel, Petr Kujal, Petr Waldauf, Alzbeta Blankova, Josef Sepitka, Dousa P, Martin Krbec, Filip Šámal, Tomas Jirasek, Jakub Jezek
Publikováno v:
The Spine Journal. 20:1125-1133
BACKGROUND CONTEXT Ligamentum flavum (LF) induced lumbar spinal stenosis (LSS) is conditioned not only by its "gathering" but especially by hypertrophy. Previous studies have examined the pathophysiology and biochemical changes that cause the hypertr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d0835de2339e9d55b9d5090194b780
https://doi.org/10.1016/j.spinee.2020.03.002
https://doi.org/10.1016/j.spinee.2020.03.002